Sanofi

Sanofi

Sanofi

Overview
Date Founded

2004

Headquarters

54, rue La Boétie,Paris, Ile-de-France 75008

Type of Company

Public

Employees (Worldwide)

107K

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Commercial Scientific Research
Medical Support Services

Company Description

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Website
Executives & Employees

Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, Legal Affairs & General Counsel

Chief Regulatory Officer

Executive Vice President & General Manager, General Medicines & Emerging Markets

Executive Vice President & General Manager, Sanofi Pasteur

President, Merial North America

Executive Vice President Head of Business Transformation

Head of IR North America & Asia

President, Global Research & Development

Subscribe now to see full list of current and former executives
Board of Directors

Founder at Weinberg Capital Partners SAS

Chief Executive Officer at Sanofi

Vice Chairman & Chief Executive Officer at Dassault Systèmes SA

Partner at Morgan, Lewis & Bockius LLP

Executive Vice President & Chief Financial Officer at L'Oréal SA

Chairman at Truffle Capital

Executive Vice President, Research & Innovation at L'Oréal SA

Former Adjunct Professor of Neuroscience at The University of Texas - Southwestern Medical Center

Subscribe now to see full list of current and former board members
Paths to Sanofi
Potential Connections via
Relationship Science
You
Sanofi
Owners & Shareholders
Details Hidden

Dodge & Cox manages diversified equity, fixed-income and balanced separate accounts and mutual funds for individuals and institutions. Individual security selection is based on the relationship of fundamentals to valuation. The firm maintains a long-term investment horizon and an employs an investment approach that emphasizes the evaluation of risk relative to opportunity. The firm adheres to a strict price discipline. Dodge & Cox's Stock Fund seeks long-term growth of principal and income. The fund's secondary objective is the generation of reasonable current income. The fund invests primarily in a diversified portfolio of the common stocks of companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth.Dodge & Cox's Global Stock Fund seeks long-term growth of principal and income through investments primarily in a diversified portfolio of equity securities issued by companies from at least 3 different countries, including emerging markets. The fund invests mainly in medium-to-large sized, well-established companies. The fund is not required to allocate investments to particular companies in set percentages. Typically, 40% of the fund's total assets are invested in the securities of non-US companies.The firm's International Stock Fund seeks long-term growth of principal and income through investments primarily in a diversified portfolio of equity securities issued by non-US companies from at least 3 different foreign countries, including emerging markets. The fund focuses on countries whose economic and political systems appear more stable and are believed to provide some protection to foreign shareholders. The fund invests mainly in medium-to-large sized, well-established companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth.Dodge & Cox's Balanced Fund seeks regular income, conservation of principal and an opportunity for long-term growth of principal and income through investments in a diversified portfolio of common stocks, preferred stocks and fixed-income securities. The fund invests in companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth. The fund typically holds no more than 75% of its total assets in stocks. The fund's invests in investment-grade fixed-income securities including US government obligations, MBS, ABS, corporate bonds, collateralized mortgage obligations and others. To a lesser extent, the fund may also invest in below investment-grade fixed income securities.The firm's Income Fund seeks a high and stable rate of current income, consistent with long-term preservation of capital with the secondary objective of capital appreciation. The fund invests primarily in a diversified portfolio of high-quality bonds and other fixed-income securities including US government obligations, MBS, ABS, corporate bonds and collateralized mortgage obligations.

Details Hidden

Amundi-IM is an active manager which invests through funds in all asset classes and main currencies. They are market leaders in Euro fixed-income, global fixed-income, money market and credit activities with a solid presence in European equities and strong niche areas of expertise in Japanese and emerging market equities.The firm believes that overall analysis of a company, including economic, social and environmental aspects, allows for better assessment of the risks and opportunities that may affect its long-term valuation.

Details Hidden

Franklin Advisers provides advisory services to a range of products and separate accounts which utilize various investment strategies including equity, fixed income, core/hybrid and multi-asset.The Franklin US Growth Equity strategies seek to provide long-term capital appreciation by investing in companies meeting the firm's criteria for growth, quality and valuation. Franklin Advisers utilizes bottom-up, fundamental analysis and focuses on high quality companies that can produce sustainable earnings and cash flow growth. They look for companies with potential for sustainable growth that is not already reflected in current stock prices. Strategies may focus on companies with a specific market-cap or on companies across all market-caps.Franklin Advisers offers actively managed fixed income strategies that emphasize rotation among different types of debt on a relative value basis; specific security selection; quantitative analysis of each security and the portfolio as a whole; and intensive credit analysis and review. Portfolios generally focus on one or more of the following: taxable and tax-exempt money market instruments; tax-exempt and taxable municipal securities; global fixed income securities; and taxable fixed income debt securities.The Franklin Core/Hybrid investment team employs bottom-up, fundamental analysis and seeks to exploit a fundamental view that differs from the market consensus regarding growth potential or valuation. They look for opportunities across asset classes including equities, fixed income and convertibles. The team also seeks to take advantage of price dislocations that result from the market's short-term focus.Franklin Advisers offers multi-asset strategies that utilize a combination of strategic, tactical and mandate research capabilities including global tactical asset allocation strategies, long-term strategic advisory mandates, packaged target date/target risk strategies, static allocation strategies and real return strategies.

Subscribe now to see full details
Recent Transactions
Details Hidden

Sanofi purchases Ablynx NV

Details Hidden

Sanofi purchases Bioverativ, Inc.

Details Hidden

Boehringer Ingelheim GmbH, C.H. Boehringer Sohn AG & Co. KG purchase Merial SAS from Sanofi

Subscribe now to see full list of recent transations
Transaction Advisors
Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Subscribe now to see 30+ more transaction advisors
Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Global Co-Head, Antitrust/Competition Practice

Advised onSanofi purchases Sanofi Genzyme

Subscribe now to see 47+ more transaction advisors
Advisors & Consultants
Subscribe now to see advisors & consultants for over 2.5 million organizations
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Subscribe now to see 17+ more consultants & advisors
Clients

Robinsons Retail Holdings, Inc. engages in the business of trading goods, commodities and merchandising of any kind. It operates through the following segments: Supermarkets, Department Stores, DIY Stores, Convenience Stores, Drug Stores, and Specialty Stores. The company was founded on February 4, 2002 and is headquartered in Quezon City, Philippines.

Universal Robina Corp. is engaged in the manufacture and distribution of consumer food products. It operates through the following segments: Branded Consumer Foods, Agro-Industrial Products, Commodity Food Products, and Corporate Business. The Branded Consumer Foods segment manufactures and distributes salty snacks, chocolates, candies, biscuits, bakery products, beverages, instant noodles, pasta and tomato-based products. The Agro-Industrial Products segment produces and distributes an animal health products, animal feeds, glucose and soya bean products; and operates hog and poultry farm. The Commodity Food Products segment refines sugar and flour as well as manufactures pasta. Its products include savory snacks, biscuits, cakes, candies, chocolates, ready-to-drink tea and coffee; juices, bottled water, energy drinks, pure and blended coffee; creamer, instant coffee and chocolate mixes; pouch and cup noodles; canned beans, sauces and tomato paste. The Corporate Business segment engages in bonds and securities investment and fund sourcing activities. The company was founded by John L. Gokongwei Jr. on September 28, 1954 and is headquartered in Quezon City, Philippines.

JG Summit Holdings, Inc. is one of the leading companies in the Philippines with business interests in: Air Transportation, Banking, Food Manufacturing, Petrochemicals, Real Estate, Hotels & Property Development, and Telecommunications.

Subscribe now to see 17 more clients
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2016
Market Capitalization
$81.9B
Total Enterprise Value
$108B
Earnings Per Share
$3.66
Revenue
$33.8B
Three Year Compounded Annual Growth Rate Of Revenue
0.87%
Five Year Compounded Annual Growth Rate Of Revenue
0.26%
Net Profit
$4.71B
Total Debt
$18.6B
Total Equity
$57.7B
Debt TEV
0.17x
EBITDA
$9.73B
EBITDAMargin
28.76%
Enterprise Value Sales
3.19x
Enterprise Value EBITDAOperating
11.11x
TEVNet Income
22.94x
Subscribe now to see full financial details
Investments
Details Hidden

NJOY LLC manufactures and distributes electronic cigarettes. Its products include kings, express starter kits, cartridge refills and onejoy disposable ecigs. The company offers a variety of rechargeable and non-rechargeable electronic cigarette products made for adult smokers. It provides nicotine and rich tobacco and menthol flavor without smoke or odor. NJOY was founded by Mark H. Weiss and Craig Weiss in 2006 and is headquartered in Scottsdale, AZ.

Details Hidden

Dystar Group manufactures and markets dyes for the textile industry. The firm specializes in textile coloration. It offers its customers a complete range of auxiliaries and colorants. Dystar Group was founded in 1995 and is headquartered in Frankfurt am Main, Germany.

Details Hidden

Thermalin Diabetes LLC develops insulin treatments for patients with diabetes. It offers ultra-rapid acting insulins that are taken before meals to dampen glucose spikes; and long acting insulins for promoting non-mealtime basal level in diabetes patients. The company was founded by Michael Weiss and Richard Berenson in 2009 and is headquartered in Cleveland, OH.

Subscribe now to see full investment details
Suppliers
Publicis Groupe SA Hospitals & Patient Services | Paris, IF

Publicis Groupe SA engages in the advertising industry. Its services include customer relationship management, direct marketing, sales promotion, events management, public relations, corporate, multicultural, and financial communications. The company was founded by Marcel Bleustein-Blanchet in 1926 and is headquartered in Paris, France.

Sodexo SA Real Estate | Issy-les-Moulineaux, IF

Sodexo SA engages in the provision of on-site services, benefits and rewards services, and personal and home care services. It offers integrated solutions which cover a variety of working and living environments and are available in client segments which include corporate, health care, education, defense, remote sites, justice services, seniors, and sports and leisure. Sodexo was founded by Pierre Bellon in 1966 and is headquartered in Issy-les-Moulineaux, France.

Neurones SA Internet Software & Services | Nanterre, IF

Neurones SA provides management consulting and information technology services. Its services include infrastructure, application and management consultations. The company operates business through its segments: Infrastructure Services, Application Services and Consulting. The Infrastructure Services segment engages in the systems and networks, service desk, workstation outsourcing, server and application outsourcing in cloud, computing mode, IT security, IT operations, IT service management and IT governance. The Application Services segment engages in the web and decision support BI, IT consulting for finance, SAP, content management and business process management, IT training and change management. The Consulting segment engages in the management and organization consulting. The company was founded on December 5, 1984 and is headquartered in Nanterre, France.

Subscribe now to see 17 more suppliers
Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, New Jersey

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Its baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. It include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Wilmington, DE

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.